Elizabeth M. Covey‐Crump

Statistics

Publications

Citations

214

H-Index

Active since

2002

Affiliations

AstraZeneca (United Kingdom)(Current)

GlaxoSmithKline (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of York

Roche (Switzerland)

Elizabeth M. Covey‐Crump is an author at AstraZeneca (United Kingdom) specializing in toxicology, temperature effects on respiration, and mutagenic impurity risk assessment.

Publications per year

2002–2019

Publications

Regulation of root respiration in two species of <i>Plantago</i> that differ in relative growth rate: the effect of short‐ and long‐term changes in temperature

Elizabeth M. Covey‐Crump, R. G. Attwood, Owen K. Atkin · Plant Cell & Environment · 2002 · 105 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies

Chris Barber, Vincent Antonucci, Jens-Christoph Baumann et al. · Regulatory Toxicology and Pharmacology · 2017 · 35 citations

Engineering, Strategy, Process Control +3

Temperature‐dependent changes in respiration rates and redox poise of the ubiquinone pool in protoplasts and isolated mitochondria of potato leaves

Elizabeth M. Covey‐Crump, Natalia V. Bykova, Charles Affourtit et al. · Physiologia Plantarum · 2006 · 26 citations

Life Sciences, Biochemistry, Plant Sciences +17

New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities

Michael J. Burns, Martin A. Ott, Andrew Teasdale et al. · Organic Process Research & Development · 2019 · 25 citations · Full text

Pharmacy, Chemical Engineering, Toxicology +17

Mutagenic Impurities: Precompetitive/Competitive Collaborative and Data Sharing Initiatives

David Elder, Angela White, James Harvey et al. · Organic Process Research & Development · 2015 · 23 citations

Pharmacy, Pharmaceutics, Toxicology +15

1–5 of 5